Outset Medical Reports First Quarter 2024 Financial Results
Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “Company”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today reported financial results for the first quarter ended March 31, 2024.
- Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “Company”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today reported financial results for the first quarter ended March 31, 2024.
- Service and other revenue was $7.7 million, an increase of 36.1% compared to $5.7 million in the first quarter of 2023.
- Product gross profit was $7.8 million, compared to $7.0 million of product gross profit in the first quarter of 2023.
- ET to discuss its first quarter 2024 financial results.